Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Therapeutic Potential for Aldosterone Inhibition in Duchenne Muscular Dystrophy

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02354352
Recruitment Status : Completed
First Posted : February 3, 2015
Last Update Posted : February 11, 2019
Sponsor:
Collaborators:
University of California, Los Angeles
University of Utah
University of Colorado, Denver
University of Kansas Medical Center
Vanderbilt University Medical Center
Information provided by (Responsible Party):
Subha Raman, Ohio State University

Results Submitted - Not Posted on ClinicalTrials.gov
Results information has been submitted to ClinicalTrials.gov by the sponsor or investigator, but is not yet publicly available (or "posted") on ClinicalTrials.gov. The submitted information may not be available if it is pending Quality Control (QC) Review by the National Library of Medicine (NLM) or if issues identified during QC review are being addressed or corrected by the sponsor or investigator. NLM's limited QC review assesses for apparent errors, deficiencies, or inconsistencies. NLM staff do not verify the scientific validity or relevance of the submitted information.
Recruitment Status : Completed
Actual Primary Completion Date : May 2018
Actual Study Completion Date : May 2018
Submission Cycle Results Submitted to ClinicalTrials.gov Results Returned after Quality Control Review
1 September 3, 2019